Overview
Status
Active
Registry date
2010-09-17
Share capital
5,000.00 PLN
Registered address
ul. Franciszka Klimczaka 16/40, 02-797 Warszawa, Poland
Electronic delivery address
AE:PL-45599-59726-HUSSW-20
Financials
Revenue history (in m)
Financial insight
- Estonian CIT: Equity includes non-zero Art. 28d line items – the company is taxed under the lump-sum regime on corporate income.
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 116 days for 2022).
- 2025not filed
- 202408/09/2025
- 202323/07/2024
- 202208/11/2023
- 202118/10/2022
- 202013/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 10.92mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 643.39kMedianUSD 20.66kAverageUSD 86.62k
Operating costs
This companyUSD 10.25mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 1.93mMedianUSD 544.32kAverageUSD 1.76m
Industry
Authorized Representatives
Beata Ewa Iwańczuk – President of the Management Board
Szymon Garkowski – Management Board Member
Manner of representation
Joint representation – the President of the Management Board and a member of the management board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Szymon Garkowskiage 47 | 2 | $540.25 | 40% |
Beata Ewa Iwańczukage 48 | 3 | $810.37 | 60% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2011-03-22.
57 1940 1076 3106 9706 0004 0000
58 1940 1076 3106 9706 0002 0000
59 1940 1076 3106 9706 0000 0000
Debt
No entries in the National Debtors Register (KRZ).
Public aid
14 public aid cases recorded, with a total value of $375,633.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 7, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $145$145 | PGE Obrót S.A. | |
| Nov 7, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $641$641 | E.ON Polska S.A. | |
| Jun 17, 2021 | Other crisis aid | $284$284 | Prezydent Miasta Stołecznego Warszawy |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-08-01 | Working capital grant for Lek-Pharma Sp. z o.o. | $26,761$26,761 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Cosmedicasp. z o.o. | $49,355,260.75 | cosmedica.pl | ||
| DR ZdrowieS.A. | $40,415,498.47 | drzdrowie.pl | ||
| MagmaxS.A. | $4,200,912.15 | magmaxsa.pl | ||
| Novopharm - Millersp. j. | $2,839,228.36 | apteka.zyj-zdrowo.com | ||
| MaglowS.A. | $1,356,219.12 | maglow.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Massmedsp. z o.o. | $49,747.70 | mojoapps.co | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A. | $2,740.83 | kwendasa.pl | ||
| Femaherbsp. z o.o. | $655.76 | femaherb.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-06-02 | Address change (Klimczaka 22/6, 02-797, Warszawa → Ul. Franciszka Klimczaka 16/40, 02-797, Warszawa) | |
| 2010-09-17 | Entered in the register |
FAQ
The main business activity of Lek-Pharma focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on September 17, 2010.
The headquarters is located at: ul. Franciszka Klimczaka 16, 02-797 Warszawa.
The management board consists of: Beata Ewa Iwańczuk (President of the Management Board) and Szymon Garkowski (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $10,924,992 in 2024, which is an increase of 11.7% compared to 2023.
Yes, the company recorded a net profit of $643,390 in 2024, meaning the company increased its profit by 17.6%.
The largest operating cost category falls under other operating costs. This category amounted to $8,451,275 in 2024, representing 82% of all operating expenses.
Last updated: 2026-06-03